GSE113375 DICER1 knockout 0 v 1 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE113375_DICER1 knockout_0_v_1_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE113375_DICER1 knockout_0_v_1_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE113375_DICER1 knockout_0_v_1_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE113375_DICER1 knockout_0_v_1_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

uncharacterized LOC101929536

Gene

vomeronasal 1 receptor 110 pseudogene

Gene

long intergenic non-protein coding RNA 1664

Gene

HLA complex P5B

Gene

RNA, 7SL, cytoplasmic 842, pseudogene

Gene

RPS3A pseudogene 55

Gene

RNA, 7SL, cytoplasmic 260, pseudogene

Gene

microRNA 4677

Gene

TATA-box binding protein associated factor 9b pseudogene 2

Gene

peptidylprolyl isomerase A pseudogene 83

  • Gene

    uncharacterized LOC101929536


  • Gene

    vomeronasal 1 receptor 110 pseudogene


  • Gene

    long intergenic non-protein coding RNA 1664



  • Gene

    RNA, 7SL, cytoplasmic 842, pseudogene


  • Gene

    RPS3A pseudogene 55


  • Gene

    RNA, 7SL, cytoplasmic 260, pseudogene



  • Gene

    TATA-box binding protein associated factor 9b pseudogene 2


  • Gene

    peptidylprolyl isomerase A pseudogene 83

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.